Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Thu Jul 06 07:06:51 UTC 2023
by
admin
on
Thu Jul 06 07:06:51 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
6K15ABL77G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
EVICEL (AUTHORIZED: HEMOSTASIS, REGULATORY)
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RAPLIXA (AUTHORIZED: HEMOSTASIS, SURGICAL)
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TACHOSIL (AUTHORIZED: HEMOSTASIS, SURGICAL)
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
||
|
NCI_THESAURUS |
C78311
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
||
|
NDF-RT |
N0000184169
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
825006
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB20551
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
100000092746
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
N0000009252
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | Increased Coagulation Factor Activity [PE] | ||
|
C81121
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
DB11571
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
6K15ABL77G
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
N0000007914
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
9002-04-4
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | |||
|
M10807
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY | Merck Index | ||
|
6K15ABL77G
Created by
admin on Thu Jul 06 07:06:51 UTC 2023 , Edited by admin on Thu Jul 06 07:06:51 UTC 2023
|
PRIMARY |
From | To |
---|---|
1_28 | 1_44 |
1_119 | 2_9 |
1_173 | 1_187 |
1_201 | 1_231 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_53 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Argatroban is capable of inhibiting the action of both free and clot-associated thrombin.
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|